HF
ROIVW

HRT Financial’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

HRT Financial’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,955
Closed -$97K – 4100
2021
Q4 		$97K Buy
+47,955
New +$73.2K ﹤0.01% 2770

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

HRT Financial's ROIVW Position: Q1 2022 in Review

HRT Financial sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2022, closing a stake of 47,955 shares — an estimated $97K sold.

HRT Financial first reported a position in ROIVW in Q4 2021 and held it in 1 quarter. The position peaked at $97K in Q4 2021. 36 funds tracked by Wall St. Rank hold ROIVW as of Q1 2022.

  • HRT Financial reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2022 after selling out during the quarter.
  • HRT Financial sold 47,955 Roivant Sciences Ltd. Warrant shares in Q1 2022, an estimated $97K.
  • HRT Financial first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 1 quarter.
  • HRT Financial's Roivant Sciences Ltd. Warrant position peaked at $97K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.